For: | Sanvisens A, Rivas I, Faure E, Espinach N, Hernandez-Rubio A, Majó X, Colom J, Muga R. Monitoring hepatitis C virus treatment rates in an Opioid Treatment Program: A longitudinal study. World J Gastroenterol 2020; 26(38): 5874-5883 [PMID: 33132641 DOI: 10.3748/wjg.v26.i38.5874] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v26/i38/5874.htm |
Number | Citing Articles |
1 |
Cristina Marcos-Fosch, Joaquín Cabezas, Javier Crespo, Maria Buti. Anti-epileptic drugs and hepatitis C therapy: Real-world experience. Journal of Hepatology 2021; 75(4): 984 doi: 10.1016/j.jhep.2021.05.040
|
2 |
Lara Grau-López, Cristina Marcos-Fosch, Constanza Daigre, Raúl Felipe Palma-Alvarez, Ariadna Rando-Segura, Jordi Llaneras, Marta Perea-Ortueta, Francisco Rodriguez-Frias, Nieves Martínez-Luna, Mar Riveiro-Barciela, Josep Antoni Ramos-Quiroga, Joan Colom, Rafael Esteban, María Buti. Barriers to linkage to care in hepatitis C patients with substance use disorders and dual diagnoses, despite centralized management. Therapeutic Advances in Gastroenterology 2021; 14 doi: 10.1177/17562848211016563
|
3 |
Sercan Karabulut. Effects of Recent IV Drug Use and Severity of Psychiatric Symptoms to Antiviral Treatment in People Who Inject Drugs. Bağımlılık Dergisi 2023; 24(1): 12 doi: 10.51982/bagimli.1105469
|
4 |
Elias Kouroumalis, Argyro Voumvouraki. Hepatitis C virus: A critical approach to who really needs treatment. World Journal of Hepatology 2022; 14(1): 1-44 doi: 10.4254/wjh.v14.i1.1
|